Anuh Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Anuh Pharma Ltd. on BSE

Load latest

Anuh Pharma Ltd.

04 Sep 2024

84.80

-1.19%

SAST

ANUH PHARMA LTD. - 506260 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bijal Kaushal Shroff

pdf

Anuh Pharma Ltd.

03 Sep 2024

84.80

-1.19%

Company Update

ANUH PHARMA LTD. - 506260 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares …

BSE India

This is to inform that with reference to the above subject, we have received intimation from Mrs. Bijal Kaushal Shroff under regulation 29(2) of SEBI (SAST) Regulations, 2011

pdf

Anuh Pharma Ltd.

03 Sep 2024

84.80

-1.19%

Company Update

ANUH PHARMA LTD. - 506260 - Disclosure As Per Regulation 7(2) And 6(2) Of SEBI (Prohibition …

BSE India

Pursuant to Regulation 7(2) and 6(2) of SEBI (PIT) Regulations, 2015 (PIT Regulations), we are enclosing herewith the disclosures received by the Company from Designated Person of the Company in Form C with respect to sale of Equity Shares of the Company.

pdf

Anuh Pharma Ltd.

03 Sep 2024

84.80

-1.19%

Company Update

ANUH PHARMA LTD. - 506260 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares …

BSE India

This is to inform that with reference to the above subject, we have received intimation from Mrs. Bijal Kaushal Shroff under regulation 29(2) of SEBI (SAST) Regulations, 2011

pdf

Anuh Pharma Ltd.

03 Sep 2024

84.80

-1.19%

Company Update

ANUH PHARMA LTD. - 506260 - Disclosure As Per Regulation 7(2) And 6(2) Of SEBI (Prohibition …

BSE India

Pursuant to Regulation 7(2) and 6(2) of SEBI (PIT) Regulations, 2015, (PIT Regulations), we are enclosing herewith the disclosures received by the Company from Designated Person of the Company in Form C with respect to sale of Equity Shares of the Company.

pdf

Anuh Pharma Ltd.

03 Sep 2024

84.80

-1.19%

SAST

ANUH PHARMA LTD. - 506260 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bijal Kaushal Shroff

pdf

Anuh Pharma Ltd.

03 Sep 2024

84.80

-1.19%

SAST

ANUH PHARMA LTD. - 506260 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bijal Kaushal Shroff

pdf

Anuh Pharma Ltd.

02 Sep 2024

84.80

-1.19%

Company Update

ANUH PHARMA LTD. - 506260 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares …

BSE India

This is to inform that with reference to the above subject, we have received intimation from Mrs. Bijal Kaushal Shroff, Immediate Relative of the Promoter Group, under Regulation 29(2) of SEBI (SAST), Regulations, 2011.

pdf

Anuh Pharma Ltd.

02 Sep 2024

84.80

-1.19%

Company Update

ANUH PHARMA LTD. - 506260 - Disclosure As Per Regulation 7(2) And 6(2) Of SEBI (Prohibition …

BSE India

Pursuant to Regulation 7(2) and 6(2) of SEBI (PIT) Regulations, 2015, (PIT Regulations), we are enclosing herewith the disclosures received by the Company from Immediate Relative of Promoter Group of the Company in Form C with respect to sale of Equity Shares of the Company.

pdf

Anuh Pharma Ltd.

30 Aug 2024

84.80

-1.19%

SAST

ANUH PHARMA LTD. - 506260 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bijal Kaushal Shroff

pdf

Is Anuh Pharma Ltd. worth buying?

232 Votes:

Buy 72.84%

Sell 10.78%

Hold 16.38%